戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  isolated from the skin of two patients with recessive dystrophic epidermolysis bullosa.
2 MGB1 is elevated in tumours of patients with Recessive Dystrophic Epidermolysis Bullosa, a disease ch
3 ells were found in the skin of children with recessive dystrophic epidermolysis bullosa after allogen
4                        To explain the milder recessive dystrophic epidermolysis bullosa and junctiona
5 or C3 and CFB in invasive cSCCs (n = 71) and recessive dystrophic epidermolysis bullosa-associated cS
6 t COL7A1 mutations in cells of patients with recessive dystrophic epidermolysis bullosa can be correc
7       The anchoring fibrils in patients with recessive dystrophic epidermolysis bullosa can be morpho
8 ndividuals with either systemic sclerosis or recessive dystrophic epidermolysis bullosa has led to th
9 The mechanobullous disease Hallopeau-Siemens recessive dystrophic epidermolysis bullosa (HS-RDEB) res
10 apable of ameliorating the manifestations of recessive dystrophic epidermolysis bullosa in humans.
11 II collagen deficiency in generalised severe recessive dystrophic epidermolysis bullosa, in which blo
12                                              Recessive dystrophic epidermolysis bullosa is a devastat
13                                              Recessive dystrophic epidermolysis bullosa is an incurab
14 th plectin defects (n = 3) or with autosomal recessive dystrophic epidermolysis bullosa (n = 4) were
15 se mutations in genomic DNA predicted severe recessive dystrophic epidermolysis bullosa or junctional
16                                          The recessive dystrophic epidermolysis bullosa patients had
17 concluded that the high caries experience in recessive dystrophic epidermolysis bullosa patients is p
18                                  Findings in recessive dystrophic epidermolysis bullosa patients' ski
19                                       In the recessive dystrophic epidermolysis bullosa patients, tra
20 esis by screening a total of 50 dominant and recessive dystrophic epidermolysis bullosa patients.
21 composed of keratinocytes from patients with recessive dystrophic epidermolysis bullosa (RDEB) and no
22 nts with the genetic skin blistering disease recessive dystrophic epidermolysis bullosa (RDEB) develo
23                                              Recessive dystrophic epidermolysis bullosa (RDEB) is a c
24                                  Importance: Recessive dystrophic epidermolysis bullosa (RDEB) is a d
25                                              Recessive dystrophic epidermolysis bullosa (RDEB) is a g
26                                              Recessive dystrophic epidermolysis bullosa (RDEB) is a r
27                                              Recessive dystrophic epidermolysis bullosa (RDEB) is a r
28                                              Recessive dystrophic epidermolysis bullosa (RDEB) is a s
29                                              Recessive dystrophic epidermolysis bullosa (RDEB) is an
30                                              Recessive dystrophic epidermolysis bullosa (RDEB) is an
31                                              Recessive dystrophic epidermolysis bullosa (RDEB) is an
32                                              Recessive dystrophic epidermolysis bullosa (RDEB) is an
33                                              Recessive dystrophic epidermolysis bullosa (RDEB) is cau
34                                              Recessive dystrophic epidermolysis bullosa (RDEB) is cau
35 c defect is demonstrated in vivo utilizing a recessive dystrophic epidermolysis bullosa (RDEB) knocko
36    Recent data suggest that individuals with recessive dystrophic epidermolysis bullosa (RDEB) only d
37 cause a human skin fragility disorder coined recessive dystrophic epidermolysis bullosa (RDEB) that i
38              Type VII collagen defects cause recessive dystrophic epidermolysis bullosa (RDEB), a bli
39 ellular matrix, we explored their utility in recessive dystrophic epidermolysis bullosa (RDEB), a bli
40  clinical observations of severe generalized recessive dystrophic epidermolysis bullosa (RDEB), a cur
41                             Individuals with recessive dystrophic epidermolysis bullosa (RDEB), a rar
42 pecific treatment is currently available for recessive dystrophic epidermolysis bullosa (RDEB), a sev
43 seases, such as the blistering skin disorder recessive dystrophic epidermolysis bullosa (RDEB), cause
44 ll carcinomas (SCCs) in patients affected by recessive dystrophic epidermolysis bullosa (RDEB).
45 is a common complication in individuals with recessive dystrophic epidermolysis bullosa (RDEB).
46  in patients from 15 unrelated families with recessive dystrophic epidermolysis bullosa (RDEB).
47 ils, and genetic analyses have revealed that recessive dystrophic epidermolysis bullosa results from
48 ubstitution, M2798K, that is associated with recessive dystrophic epidermolysis bullosa, was unable t
49 gust 2009, we treated seven children who had recessive dystrophic epidermolysis bullosa with immunomy
50 ncating mutations in 13 patients with severe recessive dystrophic epidermolysis bullosa yielding a de

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。